SCHEMBL26567723

SCHEMBL26567723

COC(=O)C1CC(C2CCCCC2)CN1C(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 4/20 0.41
EPHX1 P07099 1/20 0.40
NR1H2 P55055 3/20 0.40
ELANE P08246 1/20 0.38
MMP2 P08253 1/20 0.38
ANPEP P15144 1/20 0.38
NR1H3 Q13133 2/20 0.38
MAPT P10636 2/20 0.38
FKBP1A P62942 1/20 0.38
PTPN1 P18031 1/20 0.38
HSD17B10 Q99714 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2C19 P33261 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30392400 1.00 ALDH1A1 (0.44) ALDH1A1CYP3A4EPHX1NR1H2ELANE
SCHEMBL30571945 1.00 ALDH1A1 (0.44) ALDH1A1CYP3A4EPHX1NR1H2ELANE
SCHEMBL29523552 0.99 ALDH1A1 (0.42) ALDH1A1CYP3A4EPHX1NR1H2ELANE
SCHEMBL30181036 0.96 NR1H2 (0.40) ALDH1A1CYP3A4EPHX1NR1H2MMP2
SCHEMBL7629700 0.93 ALDH1A1 (0.42) ALDH1A1CYP3A4EPHX1NR1H2MMP2
SCHEMBL6184237 0.93 ALDH1A1 (0.42) ALDH1A1CYP3A4EPHX1NR1H2MMP2
SCHEMBL30396157 0.93 CYP3A4 (0.43) ALDH1A1CYP3A4NR1H2MMP2ANPEP
SCHEMBL18084464 0.89 NR1H2 (0.43) ALDH1A1CYP3A4NR1H2MMP2ANPEP
SCHEMBL15013224 0.88 NPC1 (0.42) ALDH1A1CYP3A4EPHX1NR1H2NR1H3
SCHEMBL1782216 0.86 HSD17B10 (0.44) EPHX1NR1H2ELANENR1H3HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 WO disclosed